Annual Short Term Debt
$187.73 M
+$186.19 M+12050.87%
December 31, 2023
Summary
- As of February 10, 2025, ACOR annual short term debt is $187.73 million, with the most recent change of +$186.19 million (+12050.87%) on December 31, 2023.
- During the last 3 years, ACOR annual short term debt has risen by +$111.16 million (+145.16%).
Performance
ACOR Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Short Term Debt
$191.47 M
+$3.74 M+1.99%
March 31, 2024
Summary
- As of February 10, 2025, ACOR quarterly short term debt is $191.47 million, with the most recent change of +$3.74 million (+1.99%) on March 31, 2024.
- Over the past year, ACOR quarterly short term debt has increased by +$189.92 million (+12205.53%).
Performance
ACOR Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
ACOR Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10000.0% | +10000.0% |
| 3 y3 years | +145.2% | +156.2% |
| 5 y5 years | +10000.0% | +2275.0% |
ACOR Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -99.2% | at high | -99.3% |
| 5 y | 5-year | at high | -99.2% | at high | -99.3% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Acorda Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $191.47 M(+2.0%) |
| Dec 2023 | $187.73 M(>+9900.0%) | $187.73 M(>+9900.0%) |
| Sep 2023 | - | $1.58 M(+0.7%) |
| Jun 2023 | - | $1.57 M(+0.7%) |
| Mar 2023 | - | $1.56 M(+0.7%) |
| Dec 2022 | $1.54 M(-81.1%) | $1.54 M(+6.3%) |
| Sep 2022 | - | $1.45 M(+7.9%) |
| Jun 2022 | - | $1.35 M(-80.9%) |
| Mar 2022 | - | $7.04 M(-14.0%) |
| Dec 2021 | $8.19 M(-89.3%) | $8.19 M(-12.1%) |
| Sep 2021 | - | $9.32 M(-13.0%) |
| Jun 2021 | - | $10.71 M(-85.7%) |
| Mar 2021 | - | $74.73 M(-2.4%) |
| Dec 2020 | $76.58 M(+817.2%) | $76.58 M(+0.8%) |
| Sep 2020 | - | $75.94 M(+0.8%) |
| Jun 2020 | - | $75.37 M(+793.3%) |
| Mar 2020 | - | $8.44 M(+1.1%) |
| Dec 2019 | $8.35 M(+1255.4%) | $8.35 M(+0.8%) |
| Sep 2019 | - | $8.28 M(+0.3%) |
| Jun 2019 | - | $8.26 M(+2.4%) |
| Mar 2019 | - | $8.06 M(+1208.8%) |
| Dec 2018 | $616.00 K(-4.5%) | $616.00 K(-1.3%) |
| Sep 2018 | - | $624.00 K(-0.8%) |
| Jun 2018 | - | $629.00 K(-5.1%) |
| Mar 2018 | - | $663.00 K(+2.8%) |
| Dec 2017 | $645.00 K(-90.8%) | $645.00 K(+1.4%) |
| Sep 2017 | - | $636.00 K(+3.4%) |
| Jun 2017 | - | $615.00 K(-18.4%) |
| Mar 2017 | - | $754.00 K(-89.3%) |
| Dec 2016 | $7.02 M(+500.6%) | $7.02 M(+519.1%) |
| Sep 2016 | - | $1.13 M(+0.7%) |
| Jun 2016 | - | $1.13 M(+0.8%) |
| Mar 2016 | - | $1.12 M(-4.4%) |
| Dec 2015 | $1.17 M | $1.17 M(+2.2%) |
| Sep 2015 | - | $1.14 M(0.0%) |
| Jun 2015 | - | $1.14 M(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $1.14 M(0.0%) |
| Dec 2014 | $1.14 M(0.0%) | $1.14 M(0.0%) |
| Sep 2014 | - | $1.14 M(0.0%) |
| Jun 2014 | - | $1.14 M(0.0%) |
| Mar 2014 | - | $1.14 M(0.0%) |
| Dec 2013 | $1.14 M(0.0%) | $1.14 M(0.0%) |
| Sep 2013 | - | $1.14 M(0.0%) |
| Jun 2013 | - | $1.14 M(0.0%) |
| Mar 2013 | - | $1.14 M(0.0%) |
| Dec 2012 | $1.14 M(0.0%) | $1.14 M(0.0%) |
| Sep 2012 | - | $1.14 M(0.0%) |
| Jun 2012 | - | $1.14 M(0.0%) |
| Mar 2012 | - | $1.14 M(0.0%) |
| Dec 2011 | $1.14 M(-0.0%) | $1.14 M(0.0%) |
| Sep 2011 | - | $1.14 M(0.0%) |
| Jun 2011 | - | $1.14 M(0.0%) |
| Mar 2011 | - | $1.14 M(-0.0%) |
| Dec 2010 | $1.14 M(>+9900.0%) | $1.14 M(0.0%) |
| Sep 2010 | - | $1.14 M(0.0%) |
| Jun 2010 | - | $1.14 M(0.0%) |
| Mar 2010 | - | $1.14 M(>+9900.0%) |
| Dec 2009 | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2007 | $187.60 K(-82.0%) | $187.60 K(-59.5%) |
| Sep 2007 | - | $463.40 K(-36.7%) |
| Jun 2007 | - | $732.40 K(-26.4%) |
| Mar 2007 | - | $994.80 K(-4.7%) |
| Dec 2006 | $1.04 M(-2.3%) | $1.04 M(+3.3%) |
| Sep 2006 | - | $1.01 M(-0.9%) |
| Jun 2006 | - | $1.02 M(-2.0%) |
| Mar 2006 | - | $1.04 M(-2.6%) |
| Dec 2005 | $1.07 M(+253.9%) | $1.07 M(-54.5%) |
| Sep 2005 | - | $2.35 M(+640.4%) |
| Dec 2004 | $301.90 K(-6.8%) | - |
| Dec 2003 | $324.00 K(+4.4%) | - |
| Sep 2003 | - | $317.00 K |
| Jun 2003 | $310.20 K | - |
FAQ
- What is Acorda Therapeutics annual short term debt?
- What is the all time high annual short term debt for Acorda Therapeutics?
- What is Acorda Therapeutics annual short term debt year-on-year change?
- What is Acorda Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Acorda Therapeutics?
- What is Acorda Therapeutics quarterly short term debt year-on-year change?
What is Acorda Therapeutics annual short term debt?
The current annual short term debt of ACOR is $187.73 M
What is the all time high annual short term debt for Acorda Therapeutics?
Acorda Therapeutics all-time high annual short term debt is $187.73 M
What is Acorda Therapeutics annual short term debt year-on-year change?
Over the past year, ACOR annual short term debt has changed by +$186.19 M (+12050.87%)
What is Acorda Therapeutics quarterly short term debt?
The current quarterly short term debt of ACOR is $191.47 M
What is the all time high quarterly short term debt for Acorda Therapeutics?
Acorda Therapeutics all-time high quarterly short term debt is $191.47 M
What is Acorda Therapeutics quarterly short term debt year-on-year change?
Over the past year, ACOR quarterly short term debt has changed by +$189.92 M (+12205.53%)